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SUMMA RY 
The molecular biology of the H L A - B 2 7 locus is rcviewed. The H L A - B 2 7 gene itself does not differ between 
healthy individuals and ankylosing Spondyl i t i s patients. Several u n i q u e features o f the H L A - B 2 7 molecule have 
been identified and one epitope was proposed to cross-react with bacterial proteins. 
K F . Y W O R D S : D N A , Intron probe, Polymorphisms, Cosmid clones. 
T H E human major histocompatibility complex ( M H C ) or H L A complex (human leucocytc antigen) 
located on the short arm of chromosome 6 contains at least 17 closely linked genes, which code for the 
heavy chains of the class I antigens. These glycosylated Polypeptides are expressed on the cell surfacc 
associated with ß 2-microglobulin. The gene produets of the highly Polymorphie loci, H L A - A , H L A -
B , and H L A - C are transplantation antigens which have been shown to serve as recognition and 
restriction elements for cytotoxic T-lymphocytes. Because of the importance of these antigens in 
clinical transplantation, the genetic polymorphism of the H L A complex has been extensively studied. 
The finding that H L A antigens are associated with disease susceptibility was rather unexpected. The 
most remarkable association is that of the H L A - B 2 7 allele and ankylosing Spondylitis (AS) with a 
relative risk of 69 [1-3]. Although the strength of the association of the HLA-B27 antigen and AS 
renders the HLA-B27 gene unique among the class I gene family, the HLA-B27 gene was only 
recently isolated. Several groups have cloned H L A - B 2 7 gene sequences (see Table I) [4-7] and the 
amino acid sequences of four H L A - B 2 7 Subtypes have also been obtained by protein sequencing [8-
11]. The gene Organization has been determined by isolating c D N A and genomic cosmid clones [4,5] 
from gene libraries construeted of D N A prepared from peripheral white blood cells (PBL) and of 
R N A isolated from a homozygous B-cell line (B L C L ) of persons with no history of disease. Seemann 
et a l . [6] reported two H L A - B 2 7 subtype sequences cloned from a B-cell line (HLA-B27.1/27.2) 
which differ only by four nucleotides resulting in three amino acid exchanges. A l l HLA-B27 
sequences are identical in the protein coding regions, the differences found in the L G 2 - c D N A 
sequence being due to c D N A cloning artefacts. It is not known whether the several nucleotkle 
differences detected in the intron sequences are due to a low genetic variabilitv of intron sequences or 
might be explained by sequencing errors. 
Although previous studies did not give any indication that the HLA-B27 molecule of AS patients 
might differ from the antigen of healthy individuals, the possibility still remained of a pathogenic 
HLA-B27 variant present in affected individuals which has not so far been detected at the protein 
level. We therefore isolated H L A - B 2 7 specific c D N A clones from a c D N A library construeted with 
T A B L E I 
T A B L E OF H L A - B 2 7 SEQUENCES 
Library Source H L A haplotype D N A sequence AS Publication 
C D genomic P B L A2 , B27/51, Cw2/4 complete gene - f Weisse/«/. [4) 
LG2 c D N A B L C L A2, B27, Cwl coding - m Szoets et al.[5\ 
B R U G genomic B L C L A3/11, B27.1/2 Cwl/2 complete gene Seemann et <//.[6] 
gap in intron 3 
K C A genomic B L C L A l l / w 2 4 , B27/w44, Cwl/5 exon 2 - 4 - m Coppin & 
McDcvitt[7] 
M R W C genomic B L C L A2/32, B14/27, Cw2 exon 2 - 4 + Coppin & 
McDevitt[7] 
M V L genomic B L C L Aw32, B27, Cw2 exon 2 - 4 — Coppin & 
McDevitt[7) 
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DNA from P B L of an AS patient (HLA-A2/23 , B27/w60, Cw2/3) and Coppin and McDevitt [7] 
cloned the genomic sequence using a B-cell line established from an affected individual. The D N A 
seqience data, derived from the protein coding and the 3'untranslated region, demonstrate that the 
HLA-B27 gene is identical in healthy persons and A S patients. 
The genomic Organization of the H L A - B 2 7 gene, that is the excon/intron structure, is similar to 
thatof other human class I genes (Fig .L) . The overall homology, between the HLA-B27 gene and 
other H L A - B alleles, e.g. H L A - B 7 , is the same as is observed when comparing two H L A - A alleles. 
A hgh degree of sequence divergence is found outside of the gene itself, in the 3' flanking region, 
whei the HLA-B27 is compared to H L A - B 7 f 12] or HLA-B51 [13], alleles for which D N A sequence 
data in this region are availablc. The genomic sequence of the HLA-B27 gene does not provide an 
obvhus explanation for the disease association of this H L A - B allele. 
H L A - B 27.1 
m RNA 
Protein 
Fic;. 1. — Structure of the HLA-B27.1 locus. 
C0M>ARIS0N OF HLA-B27 SEQUENCES U1TH OTHER HLA-B ALLELES: 
EBV. BLRF 
60 80 90 KLEB.PNEU 
B27 1 U D R E T 0 1 C K A K A Q T D R E D L R T L L R Y Y N Q S E A 
B27 2 N . . I A 
B27 3 S 
B7 . . . N . . . Y . . Q S . . N . R G 
B8 . . . N . . . F . T N T S . . N . R G 
B44 S . T N T . . Y . . N . . . A A 
B51 . . . N . . . F . T N T . . Y . . N . . . R 
B58 . . G . . R N M . . S . . . Y . . N . . I A 
Bu6: S . T N T . . Y . . S . . N . R G 
* 100 130" 150 
B27 1 G S H T L Q N M Y G C - - L S U T A A D T A A - - A R V A E Q L 
B27 3 . . E . . . . 
B7 S . . . . . R . . E . . . R 
B8 S . . . . . R D 
B44 . . . I I . R . . . . D 
B51 . . . . U . T . . . . . . E . . . . 
B58 . . . I I . R . . . . 
Bu6! R . . . . . . E . . . U 
Fic . 2 .— Comparison of H L A - B 2 7 sequences with other H L A - B antigens. 
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The protein nature of the HLA-B27 molecule is similar to other class I antigens, as the 
Polymorphie amino acid substitutions are found in the Polymorphie segments of the class I heavy 
chain (Fig. 2). Three amino acid residues (aa) are present which are unique to the HLA-B27 antigen 
and its Subtypes, and are not found in any other H L A molecule sequeneed so far. Two of these 
changes can be valued as unremarkable as they represent conservative substitutions: lysine ( K ) in aa 
position 70 and asparagine (N) in 97. Other H L A antigens also contain a basic amino acid residuc in 
these positions. These conservative substitutions are unlikely to influencc the structure or biological 
activity of the molecule in a unique fashion. One replacemcnt, however, seems unusual; position 67 is 
occupied by a potentially reactive cysteinc residuc (C) that might influencc the intcrmolecular 
interactions of HLA-B27 , due to its location in an area that is probably exposed on the surfacc of the 
membranc molecule. We are currently using site directed mutagenesis to investigate what influencc 
the HLA-B27 unique amino acid substitutions have on the structure of the molecule as detected by 
serological reagents or by allospecific cytotoxic T-lymphocytes. The structural uniqueness of H L A -
B27 which might be rcsponsible for its disease association. may be ercated by several contiguous 
amino acid residues in the Polymorphie regions. On the other hand it also might be a unique 
conformational epitope of the HLA-B27 molecule. It can be postulated that the HLA-B27 unique 
substitutions conserved among the Subtypes might be involved in the major antigenic determinants of 
HLA-B27 and might serve as a molecular site of correlation with the disease. 
Oldstone et cd. [14] have described a linear sequence of six amino acids present both in H L A -
B27.1 and in K l e b s i e l l a p n e u m o n i a e (Fig. 2) which, they propose, represents the epitope responsiblc 
for the cross-reactivity of HLA-B27 and K l e b s i e l l a , first described by Ebringer [15]. As no Single 
HLA-B27 subtype shows a preferential correlation with A S , the putative cross-reactive epitope 
should be common to all HLA-B27 variants. Only five amino acids of the K l e b s i e l l a sequence are 
conserved in HLA-B27.2 and HLA-B27.3 . The HLA-B27.3 subtype sequence in this region is 
identical to the sequence present in the H L A - B 7 [12] and the H L A - B 8 [16] antigen. It therefore 
remains to be studied if the proposed amino acid sequence of K l e b s i e l l a p n e u m o n i a e is responsible for 
the cross-reactivity observed between H L A - B 2 7 and certain microbial agents, and therefore the 
induetion of A S through molecular mimicry. 
Initially it was suggested that there might be another disease susceptibility gene for AS in strong 
linkage disequilibrium with the HLA-B27 locus (the 'two gene theory'). As it has not been possible to 
prove unequivocally that the HLA-B27 gene or its produet is directly involved in disease pathogenesis 
( lone gene theory') attempts were made to identify a second Polymorphie gene in the HLA-B27 
subregion. Several groups used class I specific probes to analyse the configuration of the HLA-B27 
gene by genomic Southern blot analyses in order to identify H L A - B 2 7 specific restriction fragment 
length polymorphisms (RFLP) which might indicate a unique genetic arrangement at the HLA-B27 
locus or detect a polymorphism varying in the presence of AS . Using a class I c D N A probe Trapani et 
a i described a Polymorphie 3.5 kb (kilobases) Taql fragment specific for genomic D N A of HLA-B27 
positive individuals [17]. This fragment is present irrespective of the disease Status. Ness and Grumct 
[18] searched for HLA-B27 specific polymorphisms employing an intragenic probe, derived from 
intron 7 of the H L A - B 7 gene on Taql digested genomic D N A . The Taql restriction enzyme is 
prcferentially used in R F L P studies, as it recognizes a four base pair sequence, thus cleaving quitc 
frequently, which contains a CpG in its recognition sequence. The C in C p G dinucleotides can be 
methylated and is thus prone to mutations. Using the intron probe four Polymorphie Taql restriction 
fragments of 2.5, 3.4, 3.8 and 4.0 or 8.0 kb were detected for HLA-B27 . The most common fragment 
among Caucasians is the 3.4 kb band, as first described by Trapani et cd. [17]. The 3.8 kb band has 
been found in onc individual and the 4.0/8.0 kb fragment in three unrelated individuals. The 2.5 kb 
Taql fragment which is characteristic for the H L A - B 7 gene [12], can also be detected in a few H L A -
B27 positive normal Caucasians but almost never appears in AS patients, suggesting a trend that is 
not yet statistically significant. Reveille et a l . reported on a 9.2 kb PvuII fragment which is present in 
HLA-B27 positive AS patients and less frequently found in HLA-B27 positive healthy individuals 
[19,20]. The presence of both HLA-B27 and the 9.2 kb PvuII R F L P in an individual conferred a 
relative risk for AS of 297, compared to 119 with HLA-B27 alone. This polymorphism which can also 
be found in non-HLA-B27 haplotypes, was detected using either a füll length H L A - B c D N A probe or 
the shorter H L A - B locus specific fragment, encoding the 3' untranslated region of the H L A - B 
m R N A . We tested a large panel of HLA-typed unrelated healthy individuals, AS patients and three 
families with at least one AS patient using the HLA-B27 füll length c D N A clone p B l [5] and the 3' 
Pstl fragment of p B l as a H L A - B locus specific probe on genomic Southern blot analyses. The 
majority of the approximately 50 individuals investigated so far possess the 9.2 kb PvuII fragment 
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I H M • •• n m 
10C0 bp HLA-B27 
F I G . 3. — T a q l restriction map of H L A - B 2 7 locus. 
described by Revcille et cd. The discrepancies between the two studies may be explained by the fact 
that two different populations were tested. The 9.2 kb PvuII fragment is not derived from the 3' end 
of the H L A - B 2 7 gene, as this region is contained on a 540 bp (base pair) PvuII fragment characteristic 
for all H L A - B alleles tested so far. 
Steere et cd. [21] used two adjacent D N A probes derived from the 5' flanking region of the H L A -
B locus just upstream of the H L A - B 7 gene which cross-hybridize with the H L A - C gene. They 
identified a 4.0 kb Taql fragment specific for the HLA-B27 gene in AS patients and controls. These 
results and the intragenic Taql cleavage sites derived from the HLA-B27 gene sequence [4] allowed 
us to construct a Taql restriction map of the HLA-B27 locus as shown in Fig. 3. 
20 40 6 0 80 
I I I I 
H L A - B 
— ; 
A B C D E 
F I G . 4. — Schematic presentation of the H L A - B subregion. The position of the H L A - B gene and the 3' class I half 
gene are shown as boxes. The orientation of the H L A - B gene 5' to 3' is indicated by the arrow. The scale above the 
cloned D N A scamenl is given in kilobases (kb). The origins of the probes used for genomic Southern blot analyses 
are shown. ( A ) 5.0 kb KpnI/Hindll l fragment: (B) 800 bp Sall/Xhol fragment of CD2.6 [4]; ( C ) 2.3 kb Pstl/EcoRI 
fragment of the 6.8 kb HLA-B27.1 EcoRI subclone; (D) 1.15 kb Taq I fragment: (E) 800 bp Pstl/Xhol fragment. 
We extended the cloned D N A of the H L A - B locus isolated in the cosmid CD2.6 containing the 
HLA-B27.1 gene, by chromosomal Walking experiments and have characterized 90 kb of this region 
(Fig. 4). A 3' half gene is localized on a 1.6 kb H ind l l l fragment 5' to the H L A - B gene which can be 
detected in all haplotypes studied so far. Several fragments were derived from the H L A - B subregion 
which can serve as single or low copy probes. The restriction fragments used in further analyses as 
H L A - B region probes are shown in Fig. 4. We searched for polymorphisms either specific for the 
H L A - B 2 7 gene or specific for AS patients. Examples of genomic restriction enzyme digests 
hybridized with the various probes are shown in Fig. 5. The probes B , D and E did not detect any 
Polymorphie restriction sites in this region. The fragment B cross-hybridized with four additional 
bands in the genomic D N A and probe E with one. Polymorphie Variation was observed at the very 5' 
end of the cloned H L A - B subregion with probe A and in the H L A - B 3' f lanking region with fragment 
C. The HLA-B27 3' flanking probe was particularly promising because it detects Polymorphie 
restriction sites with ajmost every enzyme tested, e.g. B g l l l , H i n d l l l , PvuII, Rsa, and Taql. This 
large number of observed RFLPs in the H L A - B 3' flanking region was not totally unexpected as a 
high level of divergence was observed at the D N A sequence level. The reason for this great sequence 
divergence in the H L A - B 3' flanking region is not known. No additional R F L P besides the known 3.5 
kb Taql polymorphism [17,18] was observed with the seven restriction enzymes tested which 
segregated with the H L A - B 2 7 allele. In addition, none of the Polymorphie restriction sites correlated 
with the disease Status. Further experiments are needed to study this highly Polymorphie D N A 
segment in more detail. 
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F A M I L Y S. 1 2 3 4 5 6 7 8 9 
Ö 
H L A - B 27 27 27 
A S 
6 4 
5.4 
d C 
k b B J M J IG2 B J M J k b 
k b 4 3 2 1 4 3 2 1 9.8 
6.5 
2 . 5 1.15 
1 2 3 
13.0 m ü • w* 
8.5 m . 
4.9 m m ^ 
3.5 • • ü 
F I G . 5. — Genomic Southern blot 
analyses hybridized with the various 
probes. (a) Family S., autoradiographs 
of Southern blots; (b) of Sacl (left) and 
Pstl (right) digested genomic D N A 
isolated of family S., hybridized with 
probe A ; (c) of BamHI digested 
genomic D N A from family S., 
hybridized with probe B : (d) of Bgl l l 
digested genomic D N A of H L A - B 2 7 
positive (HLA-B27/27 in lane 4 and 
H L A - B 13/27 in lane 9) and H L A - B 2 7 
negative individuals, hybridized with 
probe C ; (e) of PvuII (left) and Taql 
(right) digested genomic D N A of cell 
lines BJ (HLA-B7/8 ) , M J ( H L A - B 8 ) . 
and L G 2 (HLA-B27/27) , hvbridized 
with probe D ; (f) of Sacl (left)'and Pstl 
(right) digested genomic D N A of family 
S., hybridized with probe E . 
1 . 2 5 
1.15 
• • • 0.8 
• *• 0.65 
E 
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The tumour necrosis factor (TNF) genes a and ß (lymphotoxin) have recently been localized in 
the M H C to a region encompassing the complement factor genes and the H L A - B locus [22], These 
Polypeptide hormones are potent pleiotropins with a wide ränge of bioactivities and a major 
importance to the pathogenesis of inflammatorv responses. As the T N F genes might constitute the 
hypothetical gene X , the disease susceptibility gene for A S in strong linkage disequilibrium with the 
HLA-B27 gene, we isolated the human T N F locus in overlapping cosmid clones. In preliminary 
experiments we used a human TNF-a probe to investigate the locus in H L A - B 2 7 positive and 
negative individuals and in A S patients. No difference was found for the three groups tested. 
C O N C L U S I O N S 
In summary, several hypotheses have been proposed to explain the association of the H L A - B 2 7 
allele with spondylarthropathies. The isolation and expression of the gene encoding the HLA-B27 
antigen allows investigation of the proposed mechanisms at the single gene level independent of the 
human genetic background. The H L A - B 2 7 gene itself does not differ between healthy individuals and 
A S patients. Several unique features of the H L A - B 2 7 molecule have been identified and one epitope 
was proposed to cross-react with bacterial proteins. The isolated gene will be helpful in a study of the 
possible receptor function of this class I molecule and for an investigation of the molecular mimicry 
hypothesis. In an attempt to understand the A S - H L A - B 2 7 association the extended H L A - B region 
and the T N F genes have also been extensively investigated. Polymorphie restriction sites in this 
region associated with H L A - B 2 7 and the presence of A S could indicate a disease susceptibility gene 
linked to H L A - B 2 7 . The D N A located 5' and 3' of the H L A - B gene is Polymorphie. However, no 
R F L P was found to be significantly increased in frequency in H L A - B 2 7 positive A S patients 
compared to the H L A - B 2 7 positive control group. The failure to detect polymorphisms which 
correlate with ankylosing Spondylitis might suggest that genes important in the development of A S 
are not present in these regions. 
A C K N O W L E D G E M K N T S 
This work was supported by the Genzentrum, Munich and bv a grant of the Deutsche Forschungsgemeinschaft 
(SFB 217). 
Rl I I R H N O S 
1. Schlosstein L , Terasaki PI, Bluestone R, Pearson C M . High association of an H L - A antigen, W27, with 
ankylosing Spondyl i t i s . .V Engl J Med 1973:288:704-6. 
2. Brewerton D A . Caffev M , Hart F D . James D C O , Nicholls A , Slurrock R D . Ankvlosing Spondyli t is a n d H L A 
27. Lance! 1973;i:904-7. 
3. Tiwari JL , Terasaki PI. Ankvlosing Spondyl i t i s . In H L A und disease associations. Heidelberg: Springer 
Verlag. 1985:85-100. 
4. Weiss E H , Kuon W, Doerner C, Lang M , Riethmueller G . Organization, sequence and expression of the 
HLA-B27 gene: a molecular approach to analvze H L A a n d disease associations. I m m u n o b i o l o g v 
1985:170:367-80. 
5. Szoets H , Riethmueller G , Weiss E H . Meo T. Complete sequence o f H L A - B 2 7 c D N A identified through the 
characterizalion o f stuctural markers unique t o t h e H L A - A . - B . a n d -C allelic series. Proc Natl Acad Sei 
USA 1986:83:1428-32. 
6. Seemann O H A , Rein RS, Brown CS. Plocgh H L . Gene conversion-like mechanisms may generate 
polymorphism in human class I genes. EMBO J 1986:5:547-52. 
7. Coppin H L , McDcvitt, H O . Absence of polymorphism between H L A - B 2 7 genomic exon sequences isolated 
from normal donors a n d ankylosing S p o n d y l i t i s patients. J h n m u n o l 1986:137:2168-72. 
8. Ezquerra A , Bragado R, Vega M A . Strominger J L , Woody J N , Lopez de Castro J A . Primary structure o f 
papain-solubilized human histocompatibilitv antigen HLÄ-B27. Biochemistry 1985;24:1733-41. 
9. Vega M A , Wallace L , Rojo S, Bragado R, Aparicio P, Lopez de Castro J A . Delinealion o f functional sites in 
HLA-B27 antigens. Molecular analvsis o f H L A - B 2 7 varianl Wewak I defined bv cvtolvtic T lvmphocvtes. 
J hnmunol 1985:135:3323-32. 
10. Vega M A , Ezquerra A , Rojo S, Aparicio P, Bragado R. Lopez de Castro J A . Structural analvsis o f an H L A -
B27 functional varianl: identification o f residues that contribute to the speeificity of recognition bv 
cytolyticTlymphocyles. Proc Natl Acad Sei USA 1985:82:7394-8. 
11. Vega M A , Bragado R, ivanyi P, Pelacz J L , Lopez de Castro J A . Molecular analysis o f a functional subtype o f 
HLA-B27 : a possible evolutionary pathway for H L A - B 2 7 polymorphism. J hnmunol 1986; 137:3557—65. 
12. Biro P A , Pan J , Sood A K . Kole R, Reddy V B , Weissman S M . Sequences of human repetitive D N A , n o n -
globulin genes, a n d major histocompatibilitv locus genes. III. The major histocompatibilitv complex. Cold 
18 P A T H O G E N E S I S O F A N K Y L O S I N G S P O N D Y L I T I S A N D R A 
S p r i n g H a r b o r Svtnp Q u a n t B i o } 1983:47:1079-86. (An updated sequence was kindlv provided bv P .A. 
Biro.j 
13. Weiss E H . Unpublished results. 
14. Oldsione M B . Schwimmbeck P, DyrbergT, Fujinami R. Mimicry by virus of host molccules: implicalions for 
autoimmune disease. In: Progress of Immunology V I . New York: Academic Press. Inc.. 1986:787-95. 
15. Ebringer A , Cowling P, Ngwa-Suh N , James D C O , Ebringer RW. Crossreactivity between K l e b s i e l l a 
aerogenes species and B27 lvmphocvte antigens. In: Dausset J . Svejgaard A . eds. H L A a n d disease. Paris-
I N S E R M , 1976:58:27. 
16. Pohla H , Weiss E H . Manuscript in preparation. 
17. Trapani J A . Mickelson C A . McKenzie 1FC. A 3.5 kilobase Taql restriction fragment of genomic D N A 
segregates with HLA-B27 . hnmunogenetics 1985;24:189-92. 
18. Ness D B , Grumei FC. New polymorphisms of H L A - B 2 7 and other B locus antigens detected bv R F L P using a 
locus-speeifie probe. H u m a n h n m u n o l 1987;18:65-73. 
19. Reveille JD , McDaniel D O , Barger B O , Koopman WJ, Acton RT. Restriction fragment length polymorphism 
(RFLP) in ankvlosing Spondylitis (AS): association with a 9.2 kb PvuII f ragment ."Ar thr i t i s Rheum 
1986;29:S26. 
20. Reveille JD , McDaniel D O , Barger B O , Koopman WJ . Acton RT. Restriction fragment length polvmorphism 
(RFLP) in the seronegative spondyloarthropalhies (SNSA). A r t h r i t i s Rheum 1986;29:S32. 
21. Steerc K, Sidwell B , Leach R, Ward F E . Taurog JD, Orr HT. Use of D N A probes from the 5' flanking region 
of the H L A - B gene to examine polymorphism at the H L A - B locus. H u m a n h n m u n o l 1986:16:137-^47." 
22. Spics T. Morton C C . Nedospasov S A . Fiers W. Pious D . Strominger JL . Genes for the tumor necrosis factors 
<x and ß are linked to the human major histocompatibilitv complex. P r o c N a t l A c a d Sei USA 1986:83:8699-
702. 
23. Kottmann A H , Seemann G H A , Guessow H D , Roos M H . D N A sequence of the coding region of the H L A -
B44 gene. Immunogenetics 1986:23:396-400. 
24. Wavs JP, Coppin H L , Parham P. The complete primarv structure of HLA-Bw58. J B i o l Chem 
'1985;260:11924-33. 
DISCUSSION 
Yu: The fragments you are using as probes are perhaps only parts of the genes responsible for the 
disease susceptibility. The conditions used for hybridization may vary in different centres, which 
could explain the discrepancies. 
Did you use the samc conditions, as the other groups, which have found a difference between A S 
patients and healthy controls? 
Weiss: We used the same conditions and we exchanged D N A probes. so they could confirm our 
data. Their pattern was identical to ours. 
P a n a y i : You have looked at the structure of the region of the B27 gene. Is there any possibility 
that regulatory genes could be present in this region and explain the difference between AS patients 
and healthy controls? 
For example, do we know if up-regulation of class I antigens on B27 cells from AS patients or 
controls occurs diffcrently following Stimulation with interferon or 'tumour necrosis factor* (TNF)? 
Weiss: We compared the B27 expression with TNF-cv and TNF-ß expression by Northern blot 
analysis between AS patients and healthy individuals, and we did not find any difference. 
However, we did not stimulate the cells to see if there was any differential expression, but these 
experiments are now in progress. 
W i l l i a m s : You showed some sequence data where there was homology with B27.1. but not with 
B27.2 and B27.3. Could this homology be due to chance? 
Weiss: I do a lot of comparisons and always find homologies, both in human and mouse sytems. 
So I am not sure, that just because one finds a homology, it has to mean something. In the case of the 
short peptide sequence, if you propose that the six amino acids fragment is the cross-reactive epitope. 
that can't be the case, because the HLA-B27 Subtypes share a sequence which consists of five amino 
acids. Furthermore this same five amino acids sequence is also found in other H L A - B antigens such 
as B7 and B8. 
